NCT01391130 2019-07-23A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell CarcinomaEli Lilly and CompanyPhase 2 Terminated110 enrolled 14 charts
NCT02386111 2018-07-26A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell CarcinomaCelldex TherapeuticsPhase 1 Terminated17 enrolled
NCT02543645 2018-04-30A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerCelldex TherapeuticsPhase 1 Terminated18 enrolled